ChemComm
Communication
´
2 M. Camara, P. Williams and A. Hardman, Lancet Infect. Dis., 2002, 2,
667–676; L. C. M. Antunes, R. B. R. Ferreira, M. M. C. Buckner and
B. B. Finlay, Microbiology, 2010, 156, 2271–2282.
dramatically accelerated the aminolysis reactions, but negated
the effects of the added catalysts (entries 6–9, Table 3). Overall,
increasing solvent polarity served to decrease background
reaction rates, while protic additives increased them. It seems
reasonable to suggest that in addition to accelerating the
background reaction, the protic nature of the co-solvents
simultaneously deactivate the catalyst by inhibiting the
necessary supramolecular events that have been proposed for
thiourea catalysis (Scheme 2).9–12
Taking simple, well-establish synthetics methodologies and
applying them to biologically relevant targets helps assess the
utility of those methods in a physiological setting. In the
present case, thioureas have been demonstrated to provide
up to 10-fold rate accelerations for the aminolysis of AHLs.
However, attempts to transition these observations to condi-
tions that are more physiological (polar protic) reveal the
significant challenge of using small molecule catalysts in such
environments. Nevertheless, information of AHL fundamental
reactivity has emerged from these studies.
3 N-acyl homoserine lactones: S. R. Chhabra, C. Harty, D. S. W. Hooi,
M. Daykin, P. Williams, G. Telford, D. J. Pritchard and B. W. Bycroft,
J. Med. Chem., 2002, 46, 97–104; A. M. Pomini and A. J. Marsaioli,
J. Nat. Prod., 2008, 71, 1032–1036; M. E. A. Churchill and L. Chen,
Chem. Rev., 2011, 111, 68–85.
4 W. R. J. D. Galloway, J. T. Hodgkinson, S. D. Bowden, M. Welch and
D. R. Spring, Chem. Rev., 2011, 111, 28–67.
5 Small molecule quorum sensing inhibitors: K. M. Smith, Y. Bu and
H. Suga, Chem. Biol., 2003, 10, 563–571; F. G. Glansdorp,
G. L. Thomas, J. K. Lee, J. M. Dutton, G. P. C. Salmond, M. Welch
and D. R. Spring, Org. Biomol. Chem., 2004, 2, 3329–3336;
G. D. Geske, R. J. Wezeman, A. P. Siegel and H. E. Blackwell,
J. Am. Chem. Soc., 2005, 127, 12762–12763; T. B. Rasmussen and
M. Givskov, Microbiology, 2006, 152, 895–904; G. D. Geske,
J. C. O’Neill, D. M. Miller, M. E. Mattmann and H. E. Blackwell,
J. Am. Chem. Soc., 2007, 129, 13613–13625.
6 Enzyme, antibody mediated quorum quenching: Y. Lin, J. Xu, J. Hu,
L. Wang, S. L. Ong, J. R. Leadbetter and L. Zhang, Mol. Microbiol.,
2003, 47, 849–860; G. F. Kaufmann, R. Sartorio, S. Lee, J. M. Mee,
L. J. Altobell III, D. P. Kujawa, E. Jefferies, B. Clapham, M. M. Meijler
and K. D. Janda, J. Am. Chem. Soc., 2006, 128, 2802–2803; S. De Lamo
Marin, Y. Xu, M. M. Meijler and K. D. Janda, Bioorg. Med. Chem.
Lett., 2007, 17, 1549–1552; J. F. Teiber, S. Horke, D. C. Haines,
P. K. Chowdhary, J. Xiao, G. L. Kramer, R. W. Haley and D. I.
Draganov, Infect. Immun., 2008, 76, 2512–2519; P. B. Kapadnis,
E. Hall, M. Ramstedt, W. R. J. D. Galloway, M. Welch and
D. R. Spring, Chem. Commun., 2009, 538–540; N. Amara,
B. P. Krom, G. F. Kaufmann and M. M. Meijler, Chem. Rev., 2011,
111, 195–208.
We wish to acknowledge Dr Masa Matsumoto, Dr Silvia
Bezer-Bratu and Dr Mee-Kyung Chung for their valuable
insights and offer a special thanks to Dr Marcey L. Waters
and the US Army Research Office for their support.
7 G. Blay, L. Cardona, B. Garcia, C. L. Garcia and J. R. Pedro, Tetra-
Notes and references
ˇ
hedron Lett., 1994, 35, 931–934; W. Liu, D. D. Xu, O. Repic and
T. L. Blacklock, Tetrahedron Lett., 2001, 42, 2439–2441.
8 P. R. Schreiner, Chem. Soc. Rev., 2003, 32, 289–296; J. Connon,
Chem.–Eur. J., 2006, 12, 5418–5427.
9 A. P. Dove, R. C. Pratt, B. G. G. Lohmeijer, R. M. Waymouth and
J. L. Hedrick, J. Am. Chem. Soc., 2005, 127, 13798–13799.
‡ Piperidine was chosen during a screen of several amines for reaction
with C6-AHL. The timescale of the reaction was appropriate for
monitoring aminolysis by 1H NMR.
1 General background on bacterial quorum sensing: C. M. Waters and
B. L. Bassler, Annu. Rev. Cell Dev. Biol., 2005, 21, 319–346; 10 A. Wittkopp and P. R. Schreiner, Chem.–Eur. J., 2003, 9, 407–414;
S. R. Chhabra, B. Philipp, L. Eberl, M. Givskov, P. Williams and
C. M. Kleiner and P. R. Schreiner, Chem. Commun., 2006, 4315;
Y. Cao, Y. Lai, X. Wang, Y. Li and W. Xiao, Chem. Inform., 2007, 38, 15.
´
M. Camara, Top. Curr. Chem., 2005, 240, 279–315; S. Uroz,
Y. Dessaux and P. Oger, ChemBioChem, 2009, 10, 205–216; 11 K. M. Lippert, K. Hof, D. Gerbig, D. Ley, H. Hausmann, S. Guenther
S. T. Rutherford and B. L. Bassler, Cold Spring Harbor Perspect.
Med., 2012, 1–25.
and P. R. Schreiner, Eur. J. Org. Chem., 2012, 5919–5927.
12 Y. Takemoto, Chem. Pharm. Bull., 2010, 58, 593–601.
c
This journal is The Royal Society of Chemistry 2013
Chem. Commun., 2013, 49, 2055--2057 2057